// App-Quantinova.ai

WP70 : Do Stroke Patients Benefit from Thrombolysis Despite Contraindications or Warnings?

Researchers

Presenter

  • James C Grotta

Principal Investigators

  • Andrei V Alexandrov

  • Erich Bluhmki

  • Patrick Lyden

  • Atte Meretoja

  • Nishant K Mishra

  • Ashfaq Shuaib

  • Nils G Wahlgren

  • Christian Weimar

  • Kennedy R Lees

Medical Centers

  • Cedars-Sinai Medical Center, Los Angeles, CA

  • Karolinska University Hospital, Stockholm, Sweden

  • University Hospital of Essen, Essen, Germany

  • University of Alberta, Alberta, Canada

  • University of Melbourne, Melbourne, Australia

  • University of Glasgow, Glasgow, United Kingdom

  • Univ of Texas Medical Sch at Houston, Texas, TX

  • Standford Univ Med Ctr, Palo Alto, CA

  • University of Alabama at Birmingham, Birmingham, AL

Locations

  • Canada

  • Germany

  • United Kingdom

  • Australia

  • United States

  • Sweden

Companies

  • Boehringer Ingelheim

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Ischemic stroke

  • Diabetes

  • Stroke

Biomarkers

  • N/A

Drug/Treatment

  • Activase I.V.

  • Vista

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved